211 related articles for article (PubMed ID: 16982510)
1. Circulating adiponectin levels in Kawasaki disease.
Takeshita S; Takabayashi H; Yoshida N
Acta Paediatr; 2006 Oct; 95(10):1312-4. PubMed ID: 16982510
[TBL] [Abstract][Full Text] [Related]
2. [Value of serum soluble interleukin-2R, interleukin-6 and C-reactive protein in the early diagnosis of Kawasaki disease].
Peng Q; Wu Q; Chen CH; Hong H; Zhang LY
Zhongguo Dang Dai Er Ke Za Zhi; 2006 Jun; 8(3):208-10. PubMed ID: 16787593
[TBL] [Abstract][Full Text] [Related]
3. [Interleukin 6 activities and tumor necrosis factor-alpha levels in serum of patients with Kawasaki disease].
Matsubara T
Arerugi; 1991 Feb; 40(2):147-54. PubMed ID: 2069514
[TBL] [Abstract][Full Text] [Related]
4. Expression of myeloid-related protein-8 and -14 in patients with acute Kawasaki disease.
Hirono K; Foell D; Xing Y; Miyagawa-Tomita S; Ye F; Ahlmann M; Vogl T; Futatani T; Rui C; Yu X; Watanabe K; Wanatabe S; Tsubata S; Uese K; Hashimoto I; Ichida F; Nakazawa M; Roth J; Miyawaki T
J Am Coll Cardiol; 2006 Sep; 48(6):1257-64. PubMed ID: 16979015
[TBL] [Abstract][Full Text] [Related]
5. Elevated circulating tumor necrosis factor-alpha in patients with Kawasaki disease.
Maury CP; Salo E; Pelkonen P
J Lab Clin Med; 1989 May; 113(5):651-4. PubMed ID: 2715685
[TBL] [Abstract][Full Text] [Related]
6. Elevated levels of high-sensitivity C-reactive protein and serum amyloid-A late after Kawasaki disease: association between inflammation and late coronary sequelae in Kawasaki disease.
Mitani Y; Sawada H; Hayakawa H; Aoki K; Ohashi H; Matsumura M; Kuroe K; Shimpo H; Nakano M; Komada Y
Circulation; 2005 Jan; 111(1):38-43. PubMed ID: 15611368
[TBL] [Abstract][Full Text] [Related]
7. Relationship between adipokines and coronary artery aneurysm in children with Kawasaki disease.
Liu R; He B; Gao F; Liu Q; Yi Q
Transl Res; 2012 Aug; 160(2):131-6. PubMed ID: 22683371
[TBL] [Abstract][Full Text] [Related]
8. The acute phase nature of interleukin 6: studies in Kawasaki disease and other febrile illnesses.
Ueno Y; Takano N; Kanegane H; Yokoi T; Yachie A; Miyawaki T; Taniguchi N
Clin Exp Immunol; 1989 Jun; 76(3):337-42. PubMed ID: 2473858
[TBL] [Abstract][Full Text] [Related]
9. Plasma leptin and adiponectin in COPD exacerbations: associations with inflammatory biomarkers.
Krommidas G; Kostikas K; Papatheodorou G; Koutsokera A; Gourgoulianis KI; Roussos C; Koulouris NG; Loukides S
Respir Med; 2010 Jan; 104(1):40-6. PubMed ID: 19782551
[TBL] [Abstract][Full Text] [Related]
10. Increased serum levels of macrophage migration inhibitory factor in patients with Kawasaki disease.
Lee TJ; Chun JK; Yeon SI; Shin JS; Kim DS
Scand J Rheumatol; 2007; 36(3):222-5. PubMed ID: 17657678
[TBL] [Abstract][Full Text] [Related]
11. [Circulating interleukin-4 levels in acute phase Kawasaki disease].
Hirao J; Hibi S; Andoh T; Ichimura T
Arerugi; 1996 Oct; 45(10):1137-9. PubMed ID: 8958662
[TBL] [Abstract][Full Text] [Related]
12. [Serum gamma interferon levels in relation to tumor necrosis factor and interleukin 2 receptor in patients with Kawasaki disease involving coronary-artery lesions].
Matsubara T
Arerugi; 1990 Feb; 39(2 Pt 1):118-23. PubMed ID: 2112909
[TBL] [Abstract][Full Text] [Related]
13. [TNF-alpha, C-reactive protein and serum adiponectin modified in infertile patients with insulin resistance].
Vital Reyes VS; López Alarcón M; Zavala Ortega I; Hinojosa Cruz JC; Téllez Velasco S; Gris Calvo J
Ginecol Obstet Mex; 2008 Nov; 76(11):659-66. PubMed ID: 19065817
[TBL] [Abstract][Full Text] [Related]
14. Serum soluble E-selectin levels in Kawasaki disease.
Kim DS; Lee KY
Scand J Rheumatol; 1994; 23(5):283-6. PubMed ID: 7526448
[TBL] [Abstract][Full Text] [Related]
15. Acute Kawasaki disease is associated with reverse regulation of soluble receptor for advance glycation end products and its proinflammatory ligand S100A12.
Wittkowski H; Hirono K; Ichida F; Vogl T; Ye F; Yanlin X; Saito K; Uese K; Miyawaki T; Viemann D; Roth J; Foell D
Arthritis Rheum; 2007 Dec; 56(12):4174-81. PubMed ID: 18050248
[TBL] [Abstract][Full Text] [Related]
16. Effect of fenofibrate on adiponectin and inflammatory biomarkers in metabolic syndrome patients.
Rosenson RS
Obesity (Silver Spring); 2009 Mar; 17(3):504-9. PubMed ID: 19023279
[TBL] [Abstract][Full Text] [Related]
17. Association of plasma adiponectin and cardiovascular risk profiles in nondiabetic uremic patients on peritoneal dialysis.
Tsao YT; Hsu YJ; Chu NF; Lai CH; Chiu JS; Lin SH
J Nephrol; 2008; 21(5):744-52. PubMed ID: 18949730
[TBL] [Abstract][Full Text] [Related]
18. Immunologic abnormalities in children with acute Kawasaki disease.
Ding XT; Yang XQ; Li CR; Shen J
Chin Med J (Engl); 1993 Sep; 106(9):688-92. PubMed ID: 8287706
[TBL] [Abstract][Full Text] [Related]
19. [Serum interleukin-2 receptor in patients with Kawasaki disease].
Matsubara T
Arerugi; 1989 Jan; 38(1):49-56. PubMed ID: 2662945
[TBL] [Abstract][Full Text] [Related]
20. Nerve growth factor circulating levels are increased in Kawasaki disease: correlation with disease activity and reduced angiotensin converting enzyme levels.
Falcini F; Cerinic MM; Ermini M; Generini S; Lombardi A; Pignone A; Leoncini G; Tirassa P; Aloe L
J Rheumatol; 1996 Oct; 23(10):1798-802. PubMed ID: 8895162
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
